Late Breaking Abstract Presentation by our CEO at the ASE meetingemeuillet06 hours ago0 min readPress Release.06.2026.pdfDownload PDF • 132KB
ASE Meeting: Post- Presentation News Article https://conexiant.com/cardiology/articles/early-phase-data-support-novel-contrast-agent/
Microvascular Therapeutic Announces Investment from the Nucleus InstituteDecember 4, 2025 — Salt Lake City, UT — The Nucleus Institute’s investment committee has unanimously approved and completed an investment in Microvascular Therapeutics Inc. (MVT) through MVT’s conver
